SOURCE: Genmed Holding Corp.

Genmed Holding Corp.

April 26, 2011 09:10 ET

Wall Street Journal Radio Interviews Eric Roberts About Genmed Holding Corp.

LOS ANGELES, CA--(Marketwire - Apr 26, 2011) - Eric Roberts, Academy Award nominated actor and host for Genmed Holding Corp.'s (OTCBB: GENM) new video news release, will be interviewed today as a guest on The Daily Wrap from the Wall Street Journal with Michael Castner, the Wall Street Journal Radio Network's new talk show covering news, talk and opinion. Roberts will visit with Michael Castner by phone from Hollywood to discuss his career, entertainment news, and Roberts' recent involvement with the pharmaceutical licensing and generic drug supplier Genmed Holding Corporation in support of its plans to become the leading worldwide low cost producer of generic pharmaceutical products.

The Daily Wrap from the Wall Street Journal with Michael Castner will air at 6pm ET with refeed at 9pm ET in most markets across the country.

Host Michael Castner covers the buzz topics in breaking news, politics, tech, sports, entertainment and more with energy and a positive outlook. He's joined by leading newsmakers, opinion leaders, and more than 2,000 reporters and editors from The Wall Street Journal.

If you are interested in learning more about this innovative company, please reference their stock symbol GENM or visit the Genmed website at www.genmed.nl.

About Genmed Holding Corp.
Genmed Holding Corp. is a fully reporting publicly traded company that trades on the OTC under the symbol GENM. It is a United States and Dutch based company focusing on the delivery of low cost generic pharmaceutical drugs directly to distribution channels throughout the world. The Company began its generic drug business in 2008 and today operates primarily through its 100% owned subsidiary Genmed B.V., which is registered in the Netherlands. The Company is led by an experienced management team and board who have considerable and highly relevant experience in product development, registration, sales, marketing, distribution, operations, and financial administration.

For Additional Information, Go to the Website: www.genmed.nl

About The Wall Street Journal Radio Network
The Wall Street Journal Radio Network (http://www.wsjradio.com) has been the leading provider of business-news programming for radio stations in the United States for more than 30 years. The network serves listeners on over 400 radio stations with late-breaking business, consumer spending and financial-market news around the clock. The network is home to The Wall Street Journal Report, The Dow Jones Money Report, and Watching Your Wallet, Barron's on Investment, The Wall Street Journal This Morning and The Wall Street Journal This Weekend.

Business-news reports from The Wall Street Journal Radio Network are carried on the leading radio stations in the country - including WCBS-AM, New York; WLS-AM, Chicago; KGO-AM/KSFO-AM, San Francisco; WMAL-AM, Washington, D.C.; WWJ-AM, Detroit; KTRH-AM, Houston; WLW-AM, Cincinnati; KIRO-FM, Seattle and KTAR-FM, Phoenix. The Wall Street Journal This Morning is heard on over 200 stations including WLS-AM Chicago, WRKO-AM Boston, WPGB-FM Pittsburgh, and KNEW-AM San Francisco.

This press release contains certain "forward-looking statements" within the meaning of federal securities laws including the use of the words "expect," "anticipate," "estimate," "project," "forecast," "outlook," "target," "objective," "plan," "goal," "pursue," "on track," and similar expressions. Although the Company believes that the statements were reasonable when made, these forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance, or achievements of the company to be different from those expressed or implied. The Company assumes no obligation and does not intend to update these forward-looking statements. Among the important factors that could cause actual results to differ materially from those indicated by such forward-looking statements include, without limitation: competitive and general economic conditions, adverse effects of litigation, the timely development and acceptance of our products and services, significant changes in the competitive environment, the failure to generate or the loss of significant numbers of customers, the loss of senior management or increased government regulations.